- Home
- NDRA vs GCTK Comparison
NDRA vs GCTK Comparison
Compare NDRA & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- GCTK
- Stock Information
- Founded
- NDRA 2007
- GCTK 2001
- Country
- NDRA United States
- GCTK United States
- Employees
- NDRA N/A
- GCTK N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GCTK Medical/Dental Instruments
- Sector
- NDRA Health Care
- GCTK Health Care
- Exchange
- NDRA Nasdaq
- GCTK Nasdaq
- Market Cap
- NDRA 7.3M
- GCTK 5.9M
- IPO Year
- NDRA 2017
- GCTK N/A
- Fundamental
- Price
- NDRA $4.53
- GCTK $5.06
- Analyst Decision
- NDRA Strong Buy
- GCTK
- Analyst Count
- NDRA 1
- GCTK 0
- Target Price
- NDRA $38.00
- GCTK N/A
- AVG Volume (30 Days)
- NDRA 45.9K
- GCTK 28.9K
- Earning Date
- NDRA 11-17-2025
- GCTK 11-13-2025
- Dividend Yield
- NDRA N/A
- GCTK N/A
- EPS Growth
- NDRA N/A
- GCTK N/A
- EPS
- NDRA N/A
- GCTK N/A
- Revenue
- NDRA N/A
- GCTK N/A
- Revenue This Year
- NDRA N/A
- GCTK N/A
- Revenue Next Year
- NDRA N/A
- GCTK N/A
- P/E Ratio
- NDRA N/A
- GCTK N/A
- Revenue Growth
- NDRA N/A
- GCTK N/A
- 52 Week Low
- NDRA $2.90
- GCTK $4.22
- 52 Week High
- NDRA $11.96
- GCTK $468.00
- Technical
- Relative Strength Index (RSI)
- NDRA 42.26
- GCTK 34.24
- Support Level
- NDRA $6.06
- GCTK $4.80
- Resistance Level
- NDRA $6.80
- GCTK $6.04
- Average True Range (ATR)
- NDRA 0.84
- GCTK 0.26
- MACD
- NDRA -0.12
- GCTK -0.07
- Stochastic Oscillator
- NDRA 23.44
- GCTK 4.66
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.